Arthritis Pilot for Preserving Muscle While Losing Weight
APPLE
Weighted Vest Use to Preserve Muscle and Bone During Obesity Treatment for Osteoarthritis
1 other identifier
interventional
37
1 country
1
Brief Summary
The purpose of this research study is to see whether wearing a weighted vest during a period of active weight loss can decrease the loss of muscle and bone that occurs during weight loss. We will also determine if study participants who wear the weighted vest will have greater improvements in physical function and self-reported disability, pain, stiffness, fatigue and quality of life. This knowledge could impact weight loss programs designed for older adults. Hypothesis: Participants randomized to VEST will experience similar weight loss, but less loss of lean mass and bone density, than participants randomized to Control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Oct 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2014
CompletedFirst Posted
Study publicly available on registry
September 15, 2014
CompletedStudy Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedResults Posted
Study results publicly available
January 29, 2018
CompletedMarch 9, 2018
February 1, 2018
1.3 years
September 9, 2014
April 3, 2017
February 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Lean Mass Measured by DXA
Lean body mass (Whole body and lower-extremity lean mass are used in total calculation).
Baseline and 22 weeks
Secondary Outcomes (2)
Change in Hip Bone Density
Basleine and 22 weeks
Changes in Self-report on Fatigue Using Pittsburgh Fatigability Scale (PFS)
baseline and 22 weeks
Other Outcomes (2)
Change in Body Weight
Baseline and 22 weeks
Changes in Lower Extremity Physical Function
Baseline and 22 weeks
Study Arms (2)
Vest + Diet
EXPERIMENTALAll participants will undergo a 22 week dietary weight loss. In addition, participants will be asked to wear a weighted vest for \>10 hours a day. Weight in the vest is adjusted to match weight lost during the intervention.
No Vest + Diet
ACTIVE COMPARATORAll participants will undergo a 22 week dietary weight loss intervention. Participants in this group will be asked not to change their daily habits other than adherence to the diet protocol.
Interventions
light weight, adjustable, vest to be worn underneath clothes that weight can be added to
Participants will undergo a 22 week dietary weight loss intervention which will incorporate dietary practices for achieving weight loss while minimizing muscle and bone loss. Participants will be instructed by the Registered Dietitian to follow a low calorie diet. Individual calorie goals will be adjusted during the study if necessary to achieve a targeted weight loss goal of at least 8%, but no more than 12%, within the intervention time frame.
Eligibility Criteria
You may qualify if:
- BMI=30-40 kg/m2; Wt\<135 kg,
- self- reported MD diagnosis of osteoarthritis
- No evidence of clinical depression or other contraindications for participation in voluntary weight loss,
- Sedentary lifestyle (\<30 min, 3 d/wk of exercise),
- Able to provide own transportation to study visits and intervention,
- Not dependent on a cane or walker,
- Willing and able to consume meal replacement products,
- Not involved in other research study,
- Approved for participation by Medical Director,
- Willing to provide informed consent.
You may not qualify if:
- Weight loss or gain (±5%) in past 6 mos,
- Excessive alcohol use (\> 14 drinks/wk),
- Smoker (\>1 cigarette/d or 4/wk within yr),
- Evidence of cognitive impairment (MoCA score \<22) or difficulty with hearing or vision that would interfere with study participation, Insulin-dependent or uncontrolled diabetes (FBG \>125 mg/dl) or Hypertriglyceridemia (TG\>400 mg/dl),
- Osteoporosis (T-score\< -2.5 on hip or spine); Hip fracture, joint replacement, or spinal surgery in past 6 mos, or hyperkyphosis,
- Uncontrolled hypertension (BP\>160/90 mmHg) or abnormal kidney or liver tests per Medical Director discretion,
- Self- reported hepatitis B or C,
- Severe anemia (Hb\<10 g/100 ml),
- Past or current uncontrolled endocrine/metabolic disease, neurological or hematological disease, fibromyalgia, chronic pulmonary disease, hyperparathyroidism, rheumatoid arthritis, unstable angina, MI, cardiac surgery within 3 months,
- Cancer requiring treatment in past year except non-melanoma skin cancers,
- Regular use of medications that may influence body weight, hormones, weight loss medications, bone remodeling medication, prior use of medications that affect bone, insulin-dependent,
- Unable to tolerate vest run-in.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wake Forest University Health Scienceslead
- Medifast, Inc.collaborator
Study Sites (1)
Wake Forest Baptist Health Sticht Center on Aging
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Barbara Nicklas
- Organization
- WFSM
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara J. Nicklas, PhD
Wake Forest University Health Sciences
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2014
First Posted
September 15, 2014
Study Start
October 1, 2014
Primary Completion
January 1, 2016
Study Completion
January 1, 2016
Last Updated
March 9, 2018
Results First Posted
January 29, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will share
All data will be made available upon email request to the study PI and upon completion of a data-sharing agreement. This agreement will require that data be used only for research purposes, that no attempts be made to identify individual patients, that the data will be kept secure, that the user will not distribute the data to other researchers, that the user will return the files or destroy them once the project is completed, and that the user will acknowledge the data source. All data files will be de-identified. In addition, variables that could permit linkages to individual research participants and variables that could lead to deductive disclosure of the identity of individual subjects will be removed or recoded. We will create a link on our website that describes our study and the data available for data sharing with descriptions.